Actual Medicinal Product (AMP) Ticagrelor 60mg tablets (Medical Valley Invest AB)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
- Provenance
-
This recommendation is based on the products Brillique 60mg film-coated tablets (Astra Zeneca Limited) and Ticagrelor 60mg film coated tablets (Krka UK Ltd).
- Generic
- Ticagrelor
- Formulation
- Ticagrelor 60mg tablets
-
Ticagrelor
-
Ticagrelor 60mg tablets
-
Ticagrelor 60mg tablets (Medical Valley Invest AB)
-
-
Ticagrelor 90mg orodispersible tablets sugar free